---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-017562"
form_type: "8-K"
ticker: "TLPH"
cik: "0001427925"
company_name: "TALPHERA, INC."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:00:58.650841+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AcelRx cures Nasdaq minimum bid price deficiency; compliance regained

## Summary
- Nasdaq had notified AcelRx on April 26, 2023 of non-compliance with the $1.00 minimum bid price rule.
- On June 15, 2023, Nasdaq confirmed the company cured the deficiency and regained compliance.
- The bid price deficiency matter is now closed with no further action required.

## SEC filing metadata
- accession: 0001437749-23-017562
- form_type: 8-K
- ticker: TLPH
- cik: 0001427925
- company_name: TALPHERA, INC.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427925/000143774923017562/0001437749-23-017562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427925/000143774923017562/acrx20230615_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-017562
- JSON: https://secwatch.observer/filing/0001437749-23-017562.json
- Plain text: https://secwatch.observer/filing/0001437749-23-017562.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.